and stool softeners, which soften the stool to help it move through the digestive system more easily
The studys limitations include the cross-sectional nature, which precludes establishing causality, self-reporting of anthropometric and demographic data, which might lead to bias, and unidentified confounding
The mean weight reduction from baseline to 68 weeks was significantly greater for semaglutide 2.4 mg (-9.6%, SD 0.4) than for semaglutide 1.0 mg (-7.0%, SD 0.4) and placebo (-3.4%, SD 0.4)
Market Share Transformation The speed of Lillys market capture reflects several strategic advantages: Superior clinical efficacy drove physician preference changes Manufacturing scale-up met growing demand more effectively than competitors Pricing strategy balanced access with premium positioning Patient outcomes created strong word-of-mouth adoption Novos response has been constrained by the limitations of single-mechanism GLP-1 therapy and manufacturing capacity challenges
Q2: Is Saxenda a stimulant
These products use the same delivery method and dosages
